Dr Lalchandani Labs Ltd - 541299 - Compliance Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Compliance under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dr Lalchandani Labs Ltd - 541299 - Outcome of Board Meeting
Intimation regarding change in designation and change in constitution of Board of Directors of the Company. Dr Lalchandani Labs Ltd - 541299 - Shareholding for the Period Ended March 31, 2019
Dr Lalchandani Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here Dr Lalchandani Labs Ltd - 541299 - Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- ARJAN LALCHANDANIDesignation :- Director Dr Lalchandani Labs Ltd - 541299 - Announcement Regarding Tie Up''s With Various Hospitals
This is to bring in the kind attention of all the stakeholders that in an attempt to increase our operational revenue we have entered MOU''s with a few corporates and various health centres from whom we are expecting to generate a monthly revenue of Rs. 11.5 lacs per month collectively. Dr Lalchandani Labs Ltd - 541299 - Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- ARJAN LALCHANDANIDesignation :- Director Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Dear Sir/Madam, This is to inform you that Ms. Tanvi Malhotra, Company Secretary & Compliance Officer of the Company (holding membership no-46127) has resigned from the company & the same is effective from 1st day of December, 2018. The resignation has been accepted and she is relieved from her services from 1st December, 2018. Kindly take the above information on record.... Financial Results For The Half Year Ended 30Th September, 2018
Dear Sir/Madam, Please find enclosed herewith Un-audited Financial Results (Standalone) for half year ended 30th September, 2018 along with Limited Review Report approved by the Board of Directors of the Company at its meeting held today i.e. 14th November, 2018 in terms of Regulation 33 of Securities and Exchange Board of India ( Listing Obligations and Disclosure Requirements) Regulations, 2015.... Outcome of Board Meeting
Dear Sir/Madam, We would like to inform you that the meeting of the Board of Directors of the Company was held today, 14th November, 2018 at registered office of the company at M-20, Basement, GK-1, South Delhi-110048 at 2.00 PM, and has transacted the following: 1. Considered and approved Standalone Unaudited Financial Results (Standalone) for the Half Year ended on 30th September, 2018 along with the Limited Review Report thereon issued...